Expert Analysis

Calif. Case Raises Questions For Medical Practice Investors

The California attorney general's amicus brief in Art Center v. WCE and the California Medical Association's respo... (more story)

Previewing FDA Preapproval Access In Psychedelics EO

The second of two pathways for psychedelic drug access outlined in President Donald Trump's recent executive order... (more story)

Previewing FDA National Priority Vouchers In Psychedelics EO

President Donald Trump's recent executive order on psychedelic drug access represents a watershed moment in federa... (more story)

Deals & Corporate Governance More

Humana Investor Suit Largely Survives Dismissal Bid

Health insurer Humana can't shed proposed class action claims it misled investors about the financial impact it would see from pent-up demand for healthcare deferred amid the COVID-19 pandemic, a Delaware fede... (more story)

Acadia Investors Get Final OK For $179M Deal, Atty Fees

A Tennessee federal judge has given final approval to a $179 million settlement between investors and Acadia Healthcare Co. Inc., ending a class action that alleged the company misled investors about the stren... (more story)

How CMS Fraud Priorities Complicate Provider Acquisitions

As the Centers for Medicare & Medicaid Services steps up usage of its affiliates authority and post-transaction audits, parties contemplating the acquisition or sale of home health and hospice providers should... (more story)

IQVIA Accuses Ex-Execs, Syneos Of Poaching $180M Client

IQVIA Holdings Inc. is accusing former executives of defecting to a competitor in the clinical research organization industry and initiating a corporate raid that resulted in the loss of one customer worth at ... (more story)

4 Firms Build Astorg's $1.1B Microbiology Biz Buy

Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.

US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal

Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having repres... (more story)

Digital Health & Technology More

Deloitte Can't Duck Bulk Of Vax Software Theft Suit

Deloitte must face an inventor's trade secrets misappropriation claims accusing the consulting giant of ripping off her firm's proprietary vaccination management system and securing a multimillion-dollar gover... (more story)

Squires Snubs 10 IPRs While 4 Pass Muster In Latest Order

U.S. Patent and Trademark Office Director John Squires rejected 10 petitions for America Invents Act patent reviews and granted four challenges in an order marking the roughly half-year mark since he took over... (more story)

Colo. Fertility Clinic Must Face Trimmed Data Breach Suit

A Colorado federal judge on Tuesday narrowed a proposed class accusing a fertility clinic of failing to adequately protect patients' health and other personal information swept up in a 2024 data breach, preser... (more story)

DOJ Delay Of ADA Web Rule Undermines Equal Access

The U.S. Department of Justice's recent decision to delay compliance dates for regulations ensuring accessible government services online benefits no one, as it is long overdue for disabled Americans and doesn... (more story)

Health System Says AI Co. Botched $32M Software Project

A San Francisco-based healthcare technology company failed to deliver on promises it would consolidate a Catholic health system's data under a unified platform, breaching a projected $32 million service agreem... (more story)

Oura Hit With New Patent Suit Over Fitness Wearables

Zepp Health has hit Oura Health with a lawsuit in the Eastern District of Texas accusing the Finnish company of infringing a series of patents on wearable fitness devices, the latest salvo in a wider patent fi... (more story)

Policy & Compliance More

BREAKING: 5th Circ. Pauses Mail-Order Access To Abortion Pills

The Fifth Circuit on Friday reinstated an in-person dispensing requirement for the abortion medication mifepristone while a challenge to a Biden administration regulation brought by Louisiana officials moves forward.

Benefits Co. Inks $3M Deal To End Worker's Tobacco Fee Suit

A benefits and claims administration company will pay $3 million to end an employee's proposed class action alleging a tobacco fee on her health plan violated federal benefits law, according to the terms of th... (more story)

Calif. Sued Over Ballot Measure For Health Clinic Fund Use

Federally designated community health clinics that serve vulnerable populations sued the California secretary of state and a union to keep an initiative off the November 2026 ballot that would control their bu... (more story)

DOJ Asks 4th Circ. To Revive Children's Hospital Subpoena

The U.S. Department of Justice is asking the Fourth Circuit to reverse a district court order quashing its subpoena of transgender minor records from Children's National Hospital in Maryland, arguing that the ... (more story)

Med Groups Say HHS Stalling Challenge To Vax Changes

A Massachusetts federal judge on Friday rejected the government's request to pause discovery in a challenge by medical groups to the Trump administration's new childhood vaccination schedule while it appeals h... (more story)

Medical Practice's Assets Targeted After $49M Verdict

The Westchester Medical Group PC has only disclosed $2 million worth of insurance against a $49 million malpractice verdict that could nearly double during an expected appeal, a Connecticut cancer patient and ... (more story)